Since the birth of gene sequencing technology in the 1970s, the rapid evolution of technology and the commercialization of sequencing instruments have been accelerating humanity's understanding of life sciences. Currently, human genome sequencing and analysis can be completed in as little as 8 hours, advancing at a pace exceeding "Moore's Law" and rapidly integrating into the trends of the information age.
We are not only witnesses to this technological wave but also drivers of the fourth-generation gene sequencing technology!
The fourth generation is defined by long-read single-molecule nanopore sequencing technology. Leveraging CMOS chip electric signal detection, we strive to achieve a highly accessible, cost-effective, and ultra-high-precision high-throughput nanopore single-molecule long-read gene sequencing solution, making sequencing technology more accessible.
AXBIO, rooted in the high-tech industry, places great emphasis on independent product research and development. While establishing an independent innovation technology system, we have harvested abundant technological achievements. To date, we possess over
50+Global Patent Authorization